
Home » NZ 'LAGGING BEHIND' IN DRUG RESEARCH
NZ 'LAGGING BEHIND' IN DRUG RESEARCH
May 30, 2006
Government "hostility" is forcing pharmaceutical companies to abandon research and development in New Zealand, costing the country up to $100 million in lost investment, according to a report released today.
The New Zealand Herald
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr